Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(74)
•••
Comment by consultant99on Jan 06, 2016 11:20am
143 Views
Post# 24433381

RE:RE:Loonie below 71 cents

RE:RE:Loonie below 71 centsWith Vader vanquished it will take some time to rebuild the empire but in the mean time the low F/X rate also represents a huge discount on Nuvo itself. Dropping from .76 to 0.71 means that the cost to buy out Nuvo for a US based enterprise has declined by over 9 %.

The longer the stock price lingers and the closer we get to a ramp-up in ex-US sales (rights, royalties and supply) the more compelling a takeover looks; the falling Canadian dollar just makes it that much more inticing.

At some point the dollar will stop decling at which point hopefully Nuvo will have developed some F/X hedging capability...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities